Skip to content

Clinical trials

Essential Hypertension trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Country / region: Italy Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20062
20072
20085
20091
20101
20113
20151
20171
20182
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status8
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pavia4
Ospedale San Raffaele2
Sankyo Pharma Gmbh2
Arbor Pharmaceuticals, Inc.1
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1
Bayer1
Daiichi Sankyo1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Federico II University1
IRCCS San Raffaele1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension23
Hypertension12
Adrenocortical Adenoma1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Edema1
Fatty Liver1
Genetic Predisposition to Disease1
Hyperaldosteronism1
Insulin Resistance1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.